New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use

Кардиоваскулярная терапия и профилактика

M. G. Bubnova¹ 

[1] State Research Center for Preventive Medicine, Federal Agency on High Medical Technologies;

关键词: lipid-lowering therapy;    statins;    rosuvastatin;    high risk;    low-density lipoprotein cholesterol;    target levels;   

DOI  :  

来源: DOAJ

【 摘 要 】

The review summarizes modern principles of lipid-lowering therapy aimed at cardiovascular event risk reduction. The author describes main patient groups in need for early, aggressive lipid-lowering therapy – predominantly, statin therapy. New statin treatment tactics is presented, based on the latest results of recent large-scale clinical trials. The article also contains the results of clinical trials on a new generation statin, rosuvastatin, its lipid-lowering and anti-atherosclerotic effects, its pharmacological features and clinical use perspectives.

【 授权许可】

Unknown